L K Ball

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi An assessment of thimerosal use in childhood vaccines
    L K Ball
    Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Foodand Drug Administration, Rockville, Maryland 20852, USA
    Pediatrics 107:1147-54. 2001
  2. ncbi Evaluating the immune response to combination vaccines
    L K Ball
    Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, Food and Drug Administration, Rockville, MD 20852, USA
    Clin Infect Dis 33:S299-305. 2001
  3. ncbi Current status and future trends in vaccine regulation--USA
    L A Falk
    Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, FDA HFM 481, 1401 Rockville Pike, Rockville, MD 20852, USA
    Vaccine 19:1567-72. 2001
  4. ncbi Should the vaccine injury compensation program be expanded to cover adults?
    M A Lloyd-Puryear
    Division of Vaccine Injury Compensation, Bureau of Health Professions, U S Health Resources and Services Administration, Rockville, MD 20857, USA
    Public Health Rep 113:236-42. 1998
  5. ncbi Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system
    R Ball
    The Vaers Working Group Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA
    Pediatr Infect Dis J 20:219-23. 2001

Collaborators

Detail Information

Publications5

  1. ncbi An assessment of thimerosal use in childhood vaccines
    L K Ball
    Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Foodand Drug Administration, Rockville, Maryland 20852, USA
    Pediatrics 107:1147-54. 2001
    ..This action was prompted in part by a risk assessment from the Food and Drug Administration that is presented here...
  2. ncbi Evaluating the immune response to combination vaccines
    L K Ball
    Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, Food and Drug Administration, Rockville, MD 20852, USA
    Clin Infect Dis 33:S299-305. 2001
    ....
  3. ncbi Current status and future trends in vaccine regulation--USA
    L A Falk
    Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, FDA HFM 481, 1401 Rockville Pike, Rockville, MD 20852, USA
    Vaccine 19:1567-72. 2001
    ..If US licensure is sought, communication with the FDA throughout the clinical development of a product is essential to identify and implement the appropriate strategies for demonstrating the safety and effectiveness of a new product...
  4. ncbi Should the vaccine injury compensation program be expanded to cover adults?
    M A Lloyd-Puryear
    Division of Vaccine Injury Compensation, Bureau of Health Professions, U S Health Resources and Services Administration, Rockville, MD 20857, USA
    Public Health Rep 113:236-42. 1998
    ..After considering the staff report, NVAC chose, in 1996, not to advise the Department of Health and Human Services to include adult vaccines in VICP...
  5. ncbi Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system
    R Ball
    The Vaers Working Group Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA
    Pediatr Infect Dis J 20:219-23. 2001
    ..We identified six cases of SJS or TEN after vaccination without other obvious triggers, suggesting that SJS and TEN might very rarely be caused by vaccination. Confirmation of this hypothesis will likely require controlled studies...